at Immunovative Therapies, Ltd.
Immunovative Therapies is testing some of the most advanced and cutting-edge cancer treatments that the medical community has ever seen. Currently they are preparing to begin a Phase II/III trial in Thailand involving the use of AlloStim™ on pre-treated metastatic breast cancer patients. If results of this trial are favorable, treatment for breast cancer could enter a whole new era, reducing deaths and costs associated with the disease. Dr. Michael Har-Noy is very optimistic about the trial and is looking forward to starting it as soon as possible.
Profile Visits: 222